Moreover, the level of BMI1P1 expression might also function as a valuable biomarker in non-M3 AML (AUC = 0.906, 95% CI: 0.848–0.964, P < 0.001) (Figure 3B) and CN-AML (AUC = 0.886, 95% CI: 0.818–0.955, P < 0.001) (Figure 3C) according to ROC curves analysis. This evidence concerns the gene BMI1P1 and acute myeloid leukemia.